Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China.
Children
Hepatoblastoma
Prognosis
Surgery
Survival
Journal
Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
pubmed:
6
3
2021
medline:
11
6
2021
entrez:
5
3
2021
Statut:
ppublish
Résumé
Hepatoblastoma (HB) is the most common liver cancer in children, this study aims at analyzing the prognostic factors affecting the survival rates and summarizing the treatment experience. In this study, we reviewed patients with primary HB under the age of 14 years who underwent complete tumor resection from June 1997 to March 2019. The data of 72 patients were collected. Survival analysis was performed by Kaplan-Meier, multivariate Cox proportional hazards regression and linear mixed model for repeated measures (LMMRM). The 5-year and the 10-year event-free survival (EFS) of all patients were 78.2% and 73%, respectively. Both the 5-year and 10-year overall survival (OS) were 85.7%. Kaplan-Meier survival analysis showed that patients with tumor capsule infiltration (TCI) and patients with surgical margin less than 1 cm may also have a good prognosis. The Cox proportional hazards regression model analysis results were similar to the Kaplan-Meier analysis results. LMMRM analysis showed that there were significant differences in platelet, alpha-fetoprotein, C-reactive protein and hemoglobin values after surgery in the metastasis group (
Identifiants
pubmed: 33667139
doi: 10.1080/08880018.2020.1867266
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM